Education
About Us
Working with TipRanks
Follow Us
Jasper Therapeutics (JSPR)
NASDAQ:JSPR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -76.24M | $ -68.86M | $ -51.20M | $ -36.83M | $ -20.68M |
| EBITDA | $ -74.87M | $ -67.75M | $ -50.22M | $ -36.46M | $ 0.00 |
| Net Income | $ -71.27M | $ -64.47M | $ -37.69M | $ -30.64M | $ -31.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 71.64M | $ 86.89M | $ 38.25M | $ 84.70M | $ 19.84M |
| Total Assets | $ 79.90M | $ 94.89M | $ 48.36M | $ 93.65M | $ 23.36M |
| Total Debt | $ 1.81M | $ 2.79M | $ 3.65M | $ 2.88M | $ 1.62M |
| Net Debt | $ -69.82M | $ -84.10M | $ -34.60M | $ -81.82M | $ -18.21M |
| Total Liabilities | $ 18.23M | $ 16.45M | $ 12.37M | $ 24.14M | $ 58.49M |
| Stockholders' Equity | $ 61.67M | $ 78.44M | $ 35.99M | $ 69.52M | $ -35.13M |
| Cash Flow | |||||
| Free Cash Flow | $ -63.15M | $ -52.33M | $ -46.43M | $ -36.11M | $ -18.27M |
| Operating Cash Flow | $ -62.60M | $ -52.07M | $ -45.86M | $ -33.68M | $ -18.27M |
| Investing Cash Flow | $ -532.00K | $ -267.00K | $ -576.00K | $ -2.43M | $ 0.00 |
| Financing Cash Flow | $ 47.88M | $ 100.97M | $ 55.00K | $ 100.97M | $ 11.29M |
Jasper Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.